Children's Hospital Los Angeles

SchoolsFirst FCU Celebrates 2023 Year of Giving to Children's Miracle Network Hospitals

Retrieved on: 
Friday, April 12, 2024

TUSTIN, Calif., April 12, 2024 /PRNewswire/ -- SchoolsFirst FCU, the largest credit union serving school employees and their families, today announced that it contributed more than $365,000 in 2023 – through a combination of corporate donations and fundraising – to support Children's Miracle Network Hospitals (CMNH) and designated children's hospitals in California, including Children's Health of Orange County (CHOC), Children's Hospital Los Angeles (CHLA), Rady Children's Hospital – San Diego and UC Davis Children's Hospital.

Key Points: 
  • As a credit union serving California school employees and their families, SchoolsFirst FCU has participated in supporting Children's Miracle Network Hospitals, the charity of choice for credit unions, through partnerships with regional hospitals throughout the state.
  • SchoolsFirst FCU also assumed an active role in fundraising initiatives sponsored by "Credit Unions for Kids" (also known as "CU4Kids"), the brand under which credit unions nationwide raise funds for Children's Miracle Network Hospitals.
  • During 2023, SchoolsFirst FCU, its Members and teammembers raised funds for Children's Miracle Network Hospitals through a variety of activities and programs:
    SchoolsFirst FCU raised funds for CHOC by sponsoring the hospital's annual CHOC Walk in the Park event through fundraising activities, corporate matching funds and teammember volunteerism.
  • Classic at UC Davis, a program affiliated with the PGA Tour to support Children's Miracle Network Hospitals across the county.

Children's Hospital Los Angeles Rolls Out Nabla Copilot After Successful Pilot Program

Retrieved on: 
Wednesday, March 13, 2024

After a successful pilot program with 30 pediatric specialists, Children's Hospital Los Angeles is rolling out Nabla' ambient AI assistant to its specialists

Key Points: 
  • After a successful pilot program with 30 pediatric specialists, Children's Hospital Los Angeles is rolling out Nabla' ambient AI assistant to its specialists
    BOSTON, March 13, 2024 /PRNewswire/ -- Nabla , the company developing Nabla Copilot , the leading ambient AI assistant for clinicians, today announced it has partnered with Children's Hospital Los Angeles (CHLA) to roll out Nabla Copilot to their pediatric specialists after a successful four-week pilot program.
  • Nabla closely collaborated with CHLA's clinical team to tailor specific capabilities, ensuring that Copilot effectively met the unique requirements of pediatrics in a hospital setting.
  • "Children's Hospital Los Angeles is committed to fostering a culture of innovation in service of both our patients and team members," said Dr. Matthew Keefer, Chief Medical Informatics Officer at Children's Hospital Los Angeles.
  • "The success of the pilot program at Children's Hospital Los Angeles is not only about the metrics we achieved but also the positive impact the Nabla Copilot has had on physicians' lives," said Dr. Ed Lee , Chief Medical Officer, Nabla.

Giving Tuesday 2023: DCG Giving, a Dave Cantin Group Nonprofit, Donates More Than a Quarter Million Dollars to Boost Pediatric Cancer Research and Treatment Nationwide

Retrieved on: 
Tuesday, November 28, 2023

“I am grateful to all the benefactors within the automotive industry who supported DCG Giving with their generous donations.

Key Points: 
  • “I am grateful to all the benefactors within the automotive industry who supported DCG Giving with their generous donations.
  • This critical funding for clinical research will help transform the lives of children and young adults,” said Dave Cantin, President and CEO of The Dave Cantin Group.
  • This event focused the automotive industry’s attention on the great need for more childhood cancer research funding.
  • DCG Giving continually supports local pediatric cancer charities from coast to coast.

The Chuck Lorre Family Foundation Makes $10 Million Gift To Children’s Hospital Los Angeles To Support Research Education for Underrepresented High School and College Students

Retrieved on: 
Tuesday, December 5, 2023

The Chuck Lorre Family Foundation has pledged a total of $10 million to Children’s Hospital Los Angeles to support research education for high school and college students from under-resourced communities throughout Greater Los Angeles.

Key Points: 
  • The Chuck Lorre Family Foundation has pledged a total of $10 million to Children’s Hospital Los Angeles to support research education for high school and college students from under-resourced communities throughout Greater Los Angeles.
  • View the full release here: https://www.businesswire.com/news/home/20231205459335/en/
    Chuck Lorre with collegians Heidy Paniagua, center, and Andrea Lanz, participants in the Chuck Lorre Research Scholars Program at Children's Hospital Los Angeles.
  • (Photo: Business Wire)
    In recognition of the generous gift, Children’s Hospital Los Angeles has created the Chuck Lorre Research Scholars Program (CLRSP), which welcomed its inaugural class in the summer of 2023.
  • We’re grateful to the Chuck Lorre Family Foundation for sustaining this work for years to come.”
    The Chuck Lorre Family Foundation has been supporting Children’s Hospital Los Angeles since 2016.

iHeartMedia Los Angeles’ KOST 103.5 and Children’s Hospital Los Angeles Launch Eighth Annual Season of Giving Fundraising Campaign on Tuesday, Nov. 28

Retrieved on: 
Tuesday, November 28, 2023

For the eighth consecutive year, iHeartMedia Los Angeles’ KOST 103.5 will join Children’s Hospital Los Angeles on Giving Tuesday, Nov. 28, to celebrate the global day of giving that takes place on the first Tuesday after Thanksgiving.

Key Points: 
  • For the eighth consecutive year, iHeartMedia Los Angeles’ KOST 103.5 will join Children’s Hospital Los Angeles on Giving Tuesday, Nov. 28, to celebrate the global day of giving that takes place on the first Tuesday after Thanksgiving.
  • Starting with the Ellen K Morning Show, KOST 103.5 will dedicate 13 hours of programming to CHLA on Giving Tuesday, from 5 a.m. to 6 p.m.
  • KOST listeners are invited to support the hospital by visiting kost1035.com/chla , or by dialing #250 from a mobile phone and using keyword “CHLA” to donate.
  • Children’s Hospital Los Angeles is one of the top pediatric academic medical and research institutions in the United States and relies on the generosity of community support.

Children’s Hospital Los Angeles Recognized as National Surgical Quality Partner by American College of Surgeons

Retrieved on: 
Tuesday, November 21, 2023

Children’s Hospital Los Angeles (CHLA) has been recognized as a National Surgical Quality Partner (SQP) by the American College of Surgeons (ACS) for its long-standing dedication to the highest standards in surgical patient care.

Key Points: 
  • Children’s Hospital Los Angeles (CHLA) has been recognized as a National Surgical Quality Partner (SQP) by the American College of Surgeons (ACS) for its long-standing dedication to the highest standards in surgical patient care.
  • View the full release here: https://www.businesswire.com/news/home/20231121829446/en/
    Children’s Hospital Los Angeles leadership and team members gather in front of the newly installed American College of Surgeons Surgical Quality Partner plaque.
  • The SQP designation lets patients know that Children’s Hospital Los Angeles is dedicated to relentless self-improvement and has been verified through a detailed and rigorous review from ACS.
  • “We are immensely proud to be named an ACS Surgical Quality Partner,” said James Stein, MD, MSc, FACS, FAAP, Senior Vice President and Chief Medical Officer at Children’s Hospital Los Angeles.

Investigators at Children’s Hospital Los Angeles Find Heart Complications in Many Children Treated for MIS-C

Retrieved on: 
Wednesday, November 15, 2023

Investigators at Children’s Hospital Los Angeles analyzed results of follow-up cardiac studies for all children who had been hospitalized at CHLA for MIS-C.

Key Points: 
  • Investigators at Children’s Hospital Los Angeles analyzed results of follow-up cardiac studies for all children who had been hospitalized at CHLA for MIS-C.
  • They found that many patients with MIS-C had abnormal findings on at least one cardiac study at their 6-month follow-up.
  • Using exercise stress testing , the investigators saw a number of children who had lower than expected exercise capacity.
  • However, if the damage is permanent, these kids are potentially at lifelong risk of early heart disease.

OtoNexus Medical Technologies Accepted into Prestigious Pediatric Medical Device Accelerator, CTIP

Retrieved on: 
Tuesday, December 12, 2023

SEATTLE, Dec. 12, 2023 /PRNewswire/ -- OtoNexus Medical Technologies Inc., the innovators behind the first ultrasound-based medical device for the instant, accurate assessment of middle ear infections, is proud to announce its recent acceptance into The Consortium for Technology & Innovation in Pediatrics (CTIP). As a leader in pediatric medical device advancement, CTIP is based at two of the nation's foremost children's hospitals, Lurie Children's Hospital and Children's Hospital Los Angeles.

Key Points: 
  • As a leader in pediatric medical device advancement, CTIP is based at two of the nation's foremost children's hospitals, Lurie Children's Hospital and Children's Hospital Los Angeles.
  • The CTIP accelerator, funded by the U.S. Food and Drug Administration Pediatric Device Consortia (PDC) grant program, is designed to promote the development and commercialization of pediatric medical devices.
  • The acceptance of OtoNexus into CTIP is a promising development for pediatric healthcare providers and the families they serve.
  • For more information about OtoNexus Medical Technologies and its innovative approach to pediatric care, please visit www.otonexus.com .

49ers Arik Armstead Joins Oobli's Advisory Board as Athlete Ambassador

Retrieved on: 
Thursday, December 7, 2023

DAVIS, Calif., Dec. 7, 2023 /PRNewswire/ -- Arik Armstead, defensive lineman for the San Francisco 49ers, has joined Oobli, the leading global sweet protein manufacturer known for its healthy sugar alternatives, as an advisory board member and brand's first athlete ambassador. Sweet proteins don't affect blood sugar or the gut microbiome unlike other sugar alternatives. In this role, Armstead will advise on future product innovation and educating consumers about the game-changing potential of sweet proteins.

Key Points: 
  • DAVIS, Calif., Dec. 7, 2023 /PRNewswire/ -- Arik Armstead , defensive lineman for the San Francisco 49ers, has joined Oobli , the leading global sweet protein manufacturer known for its healthy sugar alternatives, as an advisory board member and brand's first athlete ambassador.
  • In this role, Armstead will advise on future product innovation and educating consumers about the game-changing potential of sweet proteins.
  • Armstead has experienced how too much sugar can impact his performance on the field, as well as his general wellbeing.
  • "As a father of two young children and a professional athlete, I am passionate about eating healthy and reducing our sugar intake," said Arik Armstead, San Francisco 49ers defensive lineman and founder of the Armstead Academic Project.

RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer

Retrieved on: 
Tuesday, October 31, 2023

CUMBERLAND, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.

Key Points: 
  • CUMBERLAND, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from diseases characterized by pulmonary inflammation, is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
  • Commenting on the promotion of Dr. Shuffett to Chief Medical Officer, Dean Hart, Chief Executive Officer of RS BioTherapeutics said, “Michelle has been a tremendous addition to our leadership team.
  • Michelle will Chair the TEC and that group will help guide the development of RSBT-001.”
    Commenting on her appointment, Dr. Shuffett said, “I’m thrilled to continue working with the incredible leadership team at RS BioTherapeutics in this new role.
  • Dr. Shuffett has also served in senior roles at several organizations including Synapse Medical Communications, Everyday Health, Columbia Care, and Radicle Science.